✦ LIBER ✦

Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease

✍ Scribed by Martin, F.; Volpari, C.; Steinkuhler, C.; Dimasi, N.; Brunetti, M.; Biasiol, G.; Altamura, S.; Cortese, R.; De Francesco, R.; Sollazzo, M.

Book ID: 126265012
Publisher: Oxford University Press
Year: 1997
Tongue: English
Weight: 311 KB
Volume: 10
Category: Article
ISSN: 1741-0126
DOI: 10.1093/protein/10.5.607

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evolutionary dynamics of hepatitis C vir

Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor

✍ de Bruijne, J.; Thomas, X. V.; Rebers, S. P.; Weegink, C. J.; Treitel, M. A.; Hu 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB

Structure–activity relationships for the

Structure–activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors

✍ Anton Poliakov; Anja Johansson; Eva Åkerblom; Karin Oscarsson; Bertil Samuelsson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 756 KB

MK-7009, a Potent and Selective Inhibito

MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease

✍ Liverton, N. J.; Carroll, S. S.; DiMuzio, J.; Fandozzi, C.; Graham, D. J.; Hazud 📂 Article 📅 2009 🏛 American Society for Microbiology 🌐 English ⚖ 429 KB

Resistance Analysis of the Hepatitis C V

Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir

✍ McPhee, F.; Friborg, J.; Levine, S.; Chen, C.; Falk, P.; Yu, F.; Hernandez, D.; 📂 Article 📅 2012 🏛 American Society for Microbiology 🌐 English ⚖ 1010 KB

Second-Generation Highly Potent and Sele

Second-Generation Highly Potent and Selective Inhibitors of the Hepatitis C Virus NS3 Serine Protease

✍ Chen, Kevin X.; Nair, Latha; Vibulbhan, Bancha; Yang, Weiying; Arasappan, Ashok; 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 397 KB

1168 BL-8030: A NOVEL, POTENT, SELECTIVE

1168 BL-8030: A NOVEL, POTENT, SELECTIVE, ORALLY AVAILABLE INHIBITOR OF HEPATITIS C VIRUS NS3/4A PROTEASE

✍ Halfon, P.; Courcambeck, J.; Whitaker, T.; Tharnish, P.M.; McBrayer, T.R.; Coats 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB